Advertisement

Rehabilitation of Low Vision in Aged People

  • Corrado Balacco
  • Elena Pacella
  • Fernanda Pacella
Part of the Aging Medicine book series (AGME)

Abstract

Early screening, diagnosis, and treatment of age-related eye diseases are emerging challenges for public health professionals. New techniques of evaluation and management are currently being used. The scanning laser ophthalmoscope is used for microperimetry and determination of preferred retinal locus in order to treat absolute central scotomas. Biofeedback in low vision patients using the Improved Biofeedback Integrated System has given promising results in the rehabilitation of patients. Optical aids include optical magnifiers, magnifying eyeglasses, telescopes, monoculars, Galilean, Keplerian, and electronic systems.

Public health professionals must increase public awareness about age-related eye diseases and ensure medical management and supportive care for patients.

At present the leading causes of low vision and blindness in the elderly popula tion are cataract, glaucoma, age-related macular degeneration, diabetic retinopathy, and degenerative myopia. The specific causes of visual impairment vary greatly by race/ethnicity and geographical location.

Keywords

visual impairment elderly surgical techniques facoemulsification visual field cataract 

References

  1. 1.
    Feher J, Recupero SM, Abdolrahimzadeh S, Balacco Gabrieli C. Structural evidence for membrane lipid changes in human cataract. Acta Opht. Scandinavia 1996; 74:573–577.CrossRefGoogle Scholar
  2. 2.
    West SK, Valdadrid CT. Epidemiology of risk factor for age-related cataract. Surv. Ophthalmol. 1995; 39:323–334.PubMedCrossRefGoogle Scholar
  3. 3.
    Pacella E, Pitaro I, Turri M, Lepore G.F, Balacco Gabrieli C. Ipertensione essenziale nei pazienti operati di cataratta senile: indagine clinico-statistica su 2.431 pazienti. Boll Ocul 1995;5:833–847.Google Scholar
  4. 4.
    Pacella E, Regine F, Salandri AG, Mollo R, Balacco Gabrieli C. Cataratta senile ed ipertensione essenziale: 15 anni di ricerca clinico-statistica (1980–1995). Boll Ocul 1997;6:1011–1021.Google Scholar
  5. 5.
    Pacella E, Brauneis S, Gherardi F, Balacco Gabrieli C. Anestesia e chirurgia della cataratta nei pazienti affetti da malattie sistemiche. Clin Ocul e Patol Ocul 1994;1:5–14.Google Scholar
  6. 6.
    Pacella E, Brauneis S, Gherardi F, Corubolo C, R. Zaccheo A, Pitaro I, Balacco Gabrieli C. Anestesia e chirurgia della cataratta nei “grandi vecchi”: nota 1. Clin Ocul e Patol Ocul 1995;1:9–13.Google Scholar
  7. 7.
    Pacella E, Abdolrahimzadeh B, Brauneis S, Collini S, Balacco Gabrieli C. Efficacy of preop-eratory systemic clonidine for intraocular pressure reduction in ophthalmic surgery. Annals of Ophthalmol 2001; 33(2):116–118.CrossRefGoogle Scholar
  8. 8.
    Pacella E, Picardo V, Giglio G, Migliore S, Gherardi F, Ciminelli S, Colonna GB. Variazione dell'astigmatismo corneale post-operatorio dopo chirurgia sul segmento anteriore: (ecce+iol in cp) casistica personale. nota I. Clin Ocul e Patol Ocul 1993;6:363–370.Google Scholar
  9. 9.
    Apple DJ, Solomon KD, Tetz MR, Assia EI. Posterior capsule opacification. Surv. Ophthalmol. 1992; 37:73–116.PubMedCrossRefGoogle Scholar
  10. 10.
    Kappelhof JP, Vrensen GFJM. The pathology of after cataract: a minireview. Acta Ophthalmol. 1992; Suppl. 205:13–24.PubMedGoogle Scholar
  11. 11.
    Balacco Gabrieli C, Castellano L, Palmisano C, Picardo V. New applications of Yag-laser in Q-switch mode: experimental results. Annals of Ophthalmology 1992; 24:216–9.PubMedGoogle Scholar
  12. 12.
    Cruciani F, Bozzoni Pantaleoni F, Leoni M, Pacella E, Colonna GB, Balacco Gabrieli C, De Dominicis M. L'impiego del laser a picosecondi (isl-2001) nella cataratta secondaria: nostre esperienze cliniche. Atti del LXXII Congr. S.O.I. Genova. pp. 803–807 18–21 Nov., 1992.Google Scholar
  13. 13.
    Balacco Gabrieli C, Palmisano C, Castellano L, Pacella E. Our results about the resistance of silicon iols to a q-switched nd-yag laser. Boll Ocul 1989;4:623–625.Google Scholar
  14. 14.
    Bozzoni F, Pantaleoni, Stalfieri M, Martini A, Mannino G, Balacco Gabrieli C. Trattamento parachirurgico delle opacità secondarie della capsula posteriore con Nd-Yag Laser. Incidenza delle complicanze in 538 casi. Boll Ocul 1998 n° 2 Mar–Apr.Google Scholar
  15. 15.
    Steinert RF, Puliafito CA; Humard SR, Dubak SD, Patel S. Cystoid macular edema, retinal detachment, and glaucoma after Nd:Yag laser posterior capsulotomy. Am. J Ophthalmol. 1991; 112, 372–380.Google Scholar
  16. 16.
    Drance SM. The glaucomatous visual field. Br J Ophthalmol 1972;56:186–200.PubMedCrossRefGoogle Scholar
  17. 17.
    Hart WM Jr, Becker B. The onset and evolution of glaucomatous visual field defects. Ophthalmology 1982;89:268–78.PubMedGoogle Scholar
  18. 18.
    Werner EB, Bishop VL. Visual field variability in stable glaucoma patient. Doc Ophthalm Proc Series 1987; 49:77–84.Google Scholar
  19. 19.
    The glaucoma laser trial research group: The glaucoma laser trial (GLT)2. Results of argon laser trabeculoplasty versus topical medicines. Ophthalmology 1990;97:1403–13.Google Scholar
  20. 20.
    Balacco Gabrieli C, Gherardi F, Pacella E, Sagnelli P, Cavallotti C. Il trabecolato corneo sclerale umano: analisi qantitativa delle fiber nervose colinergiche. Esper., Anno XI, 1996;1:21–24.Google Scholar
  21. 21.
    Cavallotti C, Artico M, Pescosolido N, Tranquilli-Leali FM and Pacella E. Distribution of peptidergic nerve fibers in the guinea pig trabecular meshwork. Anat Histol Embryol 2000; 29:387–391.PubMedCrossRefGoogle Scholar
  22. 22.
    Cavallotti C, Gherardi F, Pacella E, Sciamanna V, Sagnelli P, Balacco Gabrieli C. Analisi quantitativa della noradrenalina e delle fiber nervose adrenergiche nel trabecolato corneo sclerale umano. Esper Anno XI, 1996;1:25–30.Google Scholar
  23. 23.
    Gaasterland D, Tanishima T, Kuwabara T. Axoplasmic flow during chronic experimental glaucoma. Invest Ophthalmol Vis Sci 1978; 17:838.PubMedGoogle Scholar
  24. 24.
    Quigley HA, Addicks EM. Chronic experimental glaucoma in primates. Invest Ophthalmol Vis Sci 1980; 19:137.PubMedGoogle Scholar
  25. 25.
    Cartwright MJ, Anderson DR., Correlation of asymmetric damage with asymmettric intraoc ular pressure in normal tension glaucoma. Arch Ophthalmol 1988;106:898.PubMedGoogle Scholar
  26. 26.
    Greve EL, Geyssen HC. The relation between escavation and visual field in glaucoma patients with high and low intraocular pressure. V Intern Visual Fild Symp, Junk Pupl 1983;35–42.Google Scholar
  27. 27.
    Anderson DR. Glaucoma:the damage caused by pressure. Am J Ophthalmol 1989; 108:485–95.PubMedGoogle Scholar
  28. 28.
    Shulzer M, Drance SM, Carter CJ, Brooks DE, Douglas DR, Lau W. Biostatistical evidece for two distinct chronic open angle glaucoma populations. Br J Ophthalmol 1990;74:196–200.CrossRefGoogle Scholar
  29. 29.
    Pacella E., Giorgi D., D' Angelo G., Recupero S.M., Balacco Gabrieli C.Glaucoma sine ipertensione: Rassegna della letteratura. Nostre considerazioni cliniche..Boll Ocul; Anno 76 - maggio-giugno-N.3-1997.Google Scholar
  30. 30.
    Cavallotti D, Cavallotti C, Pescosolido N, Iannetti GD, Pacella E. A morphometric study of age changes in the rat optic nerve. Ophthalmologica 2001;215:366–371.PubMedCrossRefGoogle Scholar
  31. 31.
    Pacella E, Cavallotti C, Gherardi F, Pescosolido N, Balacco Gabrieli C. Analisi quantitativa degli enzimi ldh ed sdh a livello del trabecolato corneosclerale umano: eventuale ruolo nella malattia glaucomatosa. Boll Ocul 1997;4:647.Google Scholar
  32. 32.
    Neurotrasmission in human corneoscleral trabeculae. Balacco Gabrieli C, Cavallotti C, Sagnelli P, Pescosolido N, Gherardi F, Pacella E. Ann Ophthalmol 1998;30 (5): 309–311.Google Scholar
  33. 33.
    Rohen JW, Lutjen-Decroli E. “Morphology of acqueus outflow pathways in normal and glau comatous eyes.” In: The glaucomas ed. Ritch R, Shields MB, and Krupin T. 1989; vol 1 C V. Mosby co pag 41–69.Google Scholar
  34. 34.
    Greve EL, Geyssen HC. The relation between escavation and visual field in glaucoma patients with high and low intraocular pressure. V Intern Visual Fild Symp, Junk Pupl 1983;35–42.Google Scholar
  35. 35.
    Speakman JS, Leeson TS. Site of the obstruction to acqueous outflow in chronic simple glau coma. Br J of Ophthalmol 1962;46:321–335.CrossRefGoogle Scholar
  36. 36.
    Cavallotti C, Pescosolido N, Artico M, Pacella E, Cavallotti D. Occurrence of cate cholamin ergic nerve fibers in the human uveoscleral tissue in conditions of normal and raised intraocu lar pressure. International Ophthalmology 2001;24:133–139.PubMedCrossRefGoogle Scholar
  37. 37.
    Cavallotti C, Pacella E, Pescosolido N, Tranquilli-Leali FM, Feher J. Age-related changes in the human optic nerve. Can J Ophthalmol 2002; 37(7):389–394.PubMedGoogle Scholar
  38. 38.
    Cavallotti C, Cavallotti D, Pescosolido N, Pacella E. Age-related changes in rat optic nerve: morphological studies. Anat Histol Embryol 2003; 32(1):12–16.PubMedCrossRefGoogle Scholar
  39. 39.
    Vogel R, Crick RP, Shipley M, Blackmore H, Bulpitt CJ. Association between intraocular pressure and loss of visual field in chronic simple glaucoma. Br J Ophthalmol 1990;74:3–6.PubMedCrossRefGoogle Scholar
  40. 40.
    Greve EL, Geyssen HC. The relation between escavation and visual field in glaucoma patients with high and low intraocular pressure. V Intern Visual Fild Symp, Junk Pupl 1983;35–42.Google Scholar
  41. 41.
    Anderson DR. The management of the elevated intraocular pressure normal optic disks and visual fields. Surv Ophtalmol 1977; 21:479.CrossRefGoogle Scholar
  42. 42.
    Balacco Gabrieli C., Pacella E., and Abdolrahimzadeh S..“Neovascular glaucoma”.Capitolo XI, Pathophysiology of the eye, 4 Glaucoma (ed. by J. Feher) Budapest: Akademial Kiado, 1998.Google Scholar
  43. 43.
    Pescosolido N, Pacella E,Sagnelli P, Cavallotti C. Effect of systemic anti-hypertensive drugs on intraocular pressure. Nuova Stampa Medica Ital., 2005; 25(4): 5–14.Google Scholar
  44. 44.
    Pacella E, S Leopardi, S Abdolrahimzadeh, M Stalfieri, R Mollo, C Balacco Gabrieli. Terapia topica antiglaucomatosa: revisione della letteratura e prospettive terapeutiche. Boll Ocul, Anno 76 1997;5:713–723.Google Scholar
  45. 45.
    J.W.Hurst, “Medicina clinica”, ed. Masson. 1986.Google Scholar
  46. 46.
    Goodman & Gilman's. The Pharmacological Basis of Therapeutics. In: McGraw-Hill 9th EdGoogle Scholar
  47. 47.
    Pecori Giraldi J, Pacella E, Librando A, Gabrielli A, Pacella F, Galasso R, Panichi A. Tre anni di esperienza con il latanoprost nel glaucoma ad angolo aperto. Boll Ocul Anno 80 2001; 6 :593–600.Google Scholar
  48. 48.
    Pecori Girardi J, Pacella E, Librando A, Gabrieli A, Cofone C. La combinazione latanaprost timololo versus la duplice somministrazione di timololo 0.050% associato o no con latana prost: efficacia e tollerabilita' nel gpaa. Boll Ocul Anno 81 2002;5/6:11–15.Google Scholar
  49. 49.
    Alm A et al. “Latanoprost administered once daily caused a maintained reduction of intraocu lar pressure in glaucoma patients treated concomitantly with timolol”. Br J Ophthalmol 1995;79:12.PubMedCrossRefGoogle Scholar
  50. 50.
    Hartenbaum D. “The efficacy of dorzolamide, a topical carbonic anhydrase inhibitor, in com bination with timolol in the treatment of patients with open-angle glaucoma and ocular hypertension”. Clin Ther 1996,18:460.PubMedCrossRefGoogle Scholar
  51. 51.
    Meyer-Schwickerath G. Erfahrungen mit der Lichtkoagulation der Netzhaut und der Iris. Doc Ophthalmol 1956;10:91–131.CrossRefGoogle Scholar
  52. 52.
    Snyder WB. Laser coagulation of the anterior segment: I. Experimental laser iridotomy. Arch Ophthalmol 1967;77:93–98.PubMedGoogle Scholar
  53. 53.
    Perkins ES: laser iridotomy. Br med J 1970;2:580–581.PubMedCrossRefGoogle Scholar
  54. 54.
    Khuri CH. Argon laser iridectomies. Am J Ophthalmol 1973;76:490–493.PubMedGoogle Scholar
  55. 55.
    Del priore LV, Robin AL, Pollack IP: Neodymium:YAG and argon laser iridotomy: long-term follow-up in a prospective, randomized clinical trial. Ophthalmology 1988;95;1207–1211.PubMedGoogle Scholar
  56. 56.
    Thomas JV, Simmons RJ, Belcher CD III. Argon laser trabeculoplasty in the presurgical glaucoma patient. Ophthalmology 1982;89:187–197.PubMedGoogle Scholar
  57. 57.
    Weve H: Die Zyklodiatermie das corpus ciliarebei Glaukom. Zentralbl Ophthalmol 1933;29: 562–569.Google Scholar
  58. 58.
    Bietti G. Surgical intervention of the ciliary body. JAMA 1950;142:889–897.Google Scholar
  59. 59.
    Friedman DS, O'Colmain BJ, Munoz B et al. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 2004; 122:564–72.PubMedCrossRefGoogle Scholar
  60. 60.
    Klein R, Klein BE, Linton KL. Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology 1992; 99:933–943).PubMedGoogle Scholar
  61. 61.
    Pacella E, Picaro I, Pagliarini S, Vingolo E.M, Balacco Gabrieli C. Acuita' visiva nei pazienti affetti da retinite pigmentosa nelle diverse forme ereditarie. Boll Ocul 1995; 6:997–1007.Google Scholar
  62. 62.
    Balacco Gabrieli C, Pagliarini S, Bozzoni F, Pacella E,.Rasi V. La neovascolarizzazione coroidale nella degenerazione maculare correlata all‘eta’. Atti Del Corso: Neovasi Oculari. Neovasi Sottoretinici. Neovasi Retinici. Retinopatie Ischemiche, Retinopatie Proliferanti, A Cura Di: R. Brancato,G. Coscas, B. Lumbroso Roma 16–18 Nov. 1990. Cap. 2, pp. 9–15, Ed. Verduci, Roma, 1992.Google Scholar
  63. 63.
    Tatar O et al. Consequences of verteporfin photodynamic therapy on choroidal neovascular membranes. Arch Opthalmol. 2006;124:815–823.CrossRefGoogle Scholar
  64. 64.
    Balacco Gabrieli C, Castellano L, Palmisano C, Moramarco A, Pacella E. Studio controllato sull'efficacia del trattamento a lungo termine con mesoglicano nella retinopatia diabetica. Boll Ocul 1990 Anno 69;5:885–891.Google Scholar
  65. 65.
    Balacco Gabrieli C, Pacella E. Studio clinico sull' efficacia e tollerabilita' di un esparansol fato (clarema retard) nel trattamento della retinopatia arteriosclerotica. Minerva Oftalmol 1993;35:3–7.Google Scholar
  66. 66.
    Turchetti P, Pacella E, Pacella F, Bozzoni Pantaleoni F, Balacco Gabrieli C. The role adrenom-edullin in diabetic retinopathy. Invest Ophthalmol Vis Sci (ARVO). 2004; 161– 4107/ B569.Google Scholar
  67. 67.
    Balacco Gabrieli C, Chetri A, Pacella E. Light and miopia. Myopia International Research Foundation Inc., V Intern. Conf.On Myopia,I.C.O., Singapore 1990, pp. 11–21. 14–16 Marzo, 1990.Google Scholar
  68. 68.
    Scuderi G, Balacco Gabrieli C, Recupero SM. La miopia. In: Verducci ed.1993.Google Scholar
  69. 69.
    Curtin BJ. The myopia. In: Harper & Row, Philadelphia, 1985.Google Scholar
  70. 70.
    Slataper FJ. Age norms of refraction and vision. Arch Ophthalmol 1950;43:466.Google Scholar
  71. 71.
    Balacco Gabrieli C, Chetri A, Palmisano C, Castellano L, Pacella E. Eziopatogenesi della miopia. Oftalmografia N°2, Esam Futura, Roma, 1989.Google Scholar
  72. 72.
    Balacco Gabrieli C. Aetiopathogenesis of degenerative myopia. A hypothesis. Opthalmologica 1982;185:199–204.CrossRefGoogle Scholar
  73. 73.
    Balacco Gabrieli C. La mipia. Roma: verducci ed.1986.Google Scholar
  74. 74.
    Balacco Gabrieli C. l'eziopatogenesi della miopia degenerativa. Un'ipotesi. Contattologia medica 1983;1:71.Google Scholar
  75. 75.
    Raviola E, Wiesel TN. Effects of atropine on experimental myopia in macaque monokeys. ARVO Abstract. Invest. Ophtalmol. Vis. Sci. 1978;17:485.Google Scholar
  76. 76.
    Hoyt CS, Stone RD, Fromer C, Billson FA: Monocular axial myopia associated with neonatal eyelid closure in human infants. Am J Ophthalmol 1981;91:197–200.PubMedGoogle Scholar
  77. 77.
    Balacco Gabrieli C, Moramarco A, Cruciani F, Filipec M, Bozzoni Pantaleoni F, Carresi C, Pacella E. Variations des hormones steroides dans une population de myopes forts. Ophtalmologie 1995;9:473–475.Google Scholar
  78. 78.
    Pacella E, Cruciani F, Santino G, Abdolrahimzadeh B, Balacco Gabrieli C. The role of steroid hormones in hight myopia: clinical investigation. International Symposium in honour of G.B. Bietti. Current Concepts on MYOPIA - Basics, Clinical Research and Surgery; Rome, Sept. 21–24 95. Final program and abstr. book, 59, 1995.Google Scholar
  79. 79.
    C. Balacco Gabrieli, E. Pacella, A. Moramarco, F. Bozzoni, F. Cruciani. Hormonal balance in high myopia: clinical investigation. Arvo: The Association for Research of Vision and Ophthalmology. Annual Meeting Fort Lauderdale, Florida 21–26 Aprile 1996.Google Scholar
  80. 80.
    Hollwich F, Dieckhues B. The effect of natural and artificial light via the eye on hormonal and metabolic balance of animal and man. Ophthlmologica 1980;180:188–197.CrossRefGoogle Scholar
  81. 81.
    Hollwich F. Studies on the effect of the “energetic portion” of the optic nerve on functional processes and especially on the water balance. Ber. Dtsch. Ophthal. Ges. 1958;54:326.Google Scholar
  82. 82.
    Hollwich F. Effect of light via the eyes on the color changes of the frog. Klin Mbl Augen; 1958;133:748.Google Scholar
  83. 83.
    Balacco Gabrieli C, Santoro G, Santoro M, Lattanti V, Di Gioia C, Giorgino R. Plasmatic and urinary steroids in the high myopia. III note: cortisol, 17-KS (prolific females). Boll Soc Ital Biol Sper 1978;54:981.Google Scholar
  84. 84.
    Balacco Gabrieli C, Santoro G, Santoro M, Bellizzi M, Giorgino R. Plasmatic and urinary steroids in the high myopia. IV note: progesterone, 17-beta estradiol, 17OH, 17-KS. Boll Soc Ital Biol Sper 1978;54:984.Google Scholar
  85. 85.
    Aveysov ES, Winezkaija NF. Einige stoffwechsel werte fursanfte mukopolysaccaride bei der myopie. Klin Mbl Augen 1976;168:750.Google Scholar
  86. 86.
    Balacco Gabrieli C. the aetiopathogenesis of degenerative miopia. Ann. Ophthlmol 1983;15:312.Google Scholar
  87. 87.
    Wiesel TN, Raviola E. Myopia and eye enlargment after neonatal lid fusion in monkeys. Nature 1997;266:66–68.CrossRefGoogle Scholar
  88. 88.
    Raviola E, Wiesel TN. Increase in axial lenght of the monkey eye after corneal opacification. Invest. Ophtalmol Vis Sci 1979;18:1232–1236.Google Scholar
  89. 89.
    Balacco Gabrieli C, Chetri A, Palmisano C, Pacella E, Castellano C. luce e miopia. Atti del Corso Teorico Pratico “ Luce e Occhio” Roma Dic. 1989.Google Scholar
  90. 90.
    Balacco Gabrieli C, Chetri A, Pacella E. Light and miopia. V Internetional Conf. On Miopia. Syngapore, marzo 1990.Google Scholar
  91. 91.
    Trachtman J, Wallman J. Estreme miopia produced by modest changes in early visual experi ence. Science 1978;201:1249–51.PubMedCrossRefGoogle Scholar
  92. 92.
    Balacco Gabrieli C.: Aetiopathogenesis of degenerative miopia. A hypothesis. Ophthalmologica 1982;185 n.4:199.PubMedCrossRefGoogle Scholar
  93. 93.
    Balacco Gabrieli C, Santoro G, Santoro M, Scardapane P, Tundo R, Giorgino R. Plasmatic and urinary steroids in the high myopia. II note: cortisol, 17-KS (males). Boll Soc Ital Biol Sper 1978;54:978.Google Scholar
  94. 94.
    Balacco Gabrieli C, Santoro G, Santoro M, Lattanzi V, Di Gioia C, Giorgino R. Plasmatic and urinary steroids in the high myopia. III note: cortisol, 17-KS (prolific females). Boll Soc Ital Biol Sper 1978;54:984.Google Scholar
  95. 95.
    Greene PR. Miopia, the sclera; mechanical stress and the obliques. 3rd Int conf Myopia. Copenhagen. 1980.Google Scholar
  96. 96.
    Young FA. Intraocular pressure dynamics associated with accomodation. 3rd Int Conf on Myopia. Copenhagen 1980.Google Scholar
  97. 97.
    Young FA. Comunication at the Copenhagen myopia conference in relation to own paper, the distribution of myopia, in man and monkey. Doc Ophthalm Proc Ser 1980;28:5–11.Google Scholar
  98. 98.
    Tepperman J. Fisiologia metabolica ed endocrina. Pensiero scientifico edit. Roma 1969.Google Scholar
  99. 99.
    Balacco Gabrieli C, Pacella E, Abdolrahimzadeh S, Giustolisi R Excimer laser photorefrac tive keratectomy for high miopia. Advance Ophthalmic Laser Surgery an International Training Course, Interlaken, Switzerland 26–28 giugno 1997.Google Scholar
  100. 100.
    Pacella E, Abdolrahimzadeh S, Abdolrahimzadeh B, Mollo R, Balacco Gabrieli C Excimer laser photorefractive keratectomy for hygh myopia and myopic astigmatism. Invest Ophthalmol Vis Sci (ARVO). 1998; 1608 B489: S347.Google Scholar
  101. 101.
    Balacco Gabrieli C, Pacella E, Abdolrahimzadeh S. Excimer laser photorefractive keratectomy for hig myopia and myopic astigmatism. Ophthalmic Surgery Lasers 1999;30(6):442–448.Google Scholar
  102. 102.
    Pacella E, Pacella F, Abdolrahimzadeh S, Vulcano C.L, Brandozzi M, Mollo R, Balacco Gabrieli C. Photorefractive keratectomy in the manegement of high myiopic defect, tissue saving vs planoscan. Invest Ophthalmol Vis Sci (ARVO). 2006;-3621/B105.Google Scholar
  103. 103.
    Balacco Gabrieli C, Lorusso V, Moramarco A, Pacella E. Myopic cataract and implantation. Acta Of The V° Congr.Intern., On Cataract And Refractive Microsurgery pp. 143–144. Proceedings Of The V International Congress Florence, Italy; Giugno 1989. A.E Maumenee, W.J. Stark, I. Esente. Cappelli Edit. Bologna, 1991.Google Scholar
  104. 104.
    Contestabile MT, Recupero SM, Palladino D, De Stefanis M, Abdolrahimzadeh S, Suppressa F, and C Balacco Gabrieli al “A new method of biofeedback in the management of low vision Eye, Jul 2002; 16 (4):472–80.Google Scholar
  105. 105.
    Giorgi D, Contestabile M, Pacella E, Balacco Gabrieli C. An instrument for biofeedback applied to vision. Applied Psychophysiology and Biofeedback. 2005;30(7):389–395.PubMedCrossRefGoogle Scholar
  106. 106.
    Balacco Gabrieli C, Giorgi, Dario, Pacella E, Turchetti P, Pacella F, Mascaro T, Vingolo E, Vulcano C.L Biofeedback and visual rehabilitation in patients with macular degeneration. Invest.Ophthalmol. Vis. Sci. (ARVO). 2006;- 798/B719.Google Scholar

Copyright information

© Humana Press, a part of Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Corrado Balacco
    • 1
  • Elena Pacella
    • 1
  • Fernanda Pacella
    • 1
  1. 1.Department of Ophthalmologic SciencesUniversity of Rome “La Sapienza,”RomeItaly

Personalised recommendations